Foundation Medicine, Novartis partner up on companion diagnostics in oncology
The partnership will also enable Foundation Medicine to move into ex-US markets like Japan, where it is working with drugmaker Chugai.
Foundation Medicine launches liquid biopsy test
Chief Commercial Officer Tom Civik said he sees reimbursement of its NGS test as opening the door for liquid biopsy reimbursement as well.
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Merck, Foundation Medicine to build companion diagnostics for Keytruda
Companies to create tests for tissue-agnostic MSI-H and dMMR cancers using Foundation's next-generation sequencing platform.